Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.7B |
| 2 |
Microsoft
MSFT
|
+$660M |
| 3 |
ExxonMobil
XOM
|
+$621M |
| 4 |
Apple
AAPL
|
+$520M |
| 5 |
UnitedHealth
UNH
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$957M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$477M |
| 3 |
GE Aerospace
GE
|
+$377M |
| 4 |
AEL
American Equity Investment Life Holding Company
AEL
|
+$271M |
| 5 |
WIRE
Encore Wire Corp
WIRE
|
+$200M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Financials | 16.95% |
| 3 | Industrials | 12.44% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Healthcare | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NOTV
3326
DELISTED
Inotiv
NOTV
| $42.2K | ﹤0.01% |
25,410
-4,919
| -16% | -$18.1K |
|
3327
Stabilis Solutions
SLNG
$88.6M
| $40.9K | ﹤0.01% |
+10,613
| New | +$43.3K |
|
3328
Lineage Cell Therapeutics
LCTX
$277M
| $40.3K | ﹤0.01% |
40,449
| – | – |
|
3329
Anixa Biosciences
ANIX
$121M
| $38.8K | ﹤0.01% |
17,544
-3,633
| -17% | -$10.3K |
|
3330
Exagen
XGN
$113M
| $38.3K | ﹤0.01% |
21,039
-5,398
| -20% | -$9.14K |
|
3331
Rigetti Computing
RGTI
$4.94B
| $37.8K | ﹤0.01% |
35,361
| – | – |
|
3332
Educational Development Corp
EDUC
$11.8M
| $37.5K | ﹤0.01% |
19,822
+2,725
| +16% | +$5.67K |
|
3333
Nephros
NEPH
$38M
| $37.2K | ﹤0.01% |
+17,631
| New | +$38K |
|
3334
IZEA Worldwide
IZEA
$59.2M
| $37K | ﹤0.01% |
15,741
+5,140
| +48% | +$13.2K |
|
3335
Arts-Way Manufacturing Co
ARTW
$11.3M
| $36.9K | ﹤0.01% |
22,795
-8,148
| -26% | -$14.9K |
|
3336
Eton Pharmaceutcials
ETON
$1.34B
| $34.8K | ﹤0.01% |
10,564
| – | – |
|
|
LGO
3337
Largo
LGO
$59.4M
| $31.2K | ﹤0.01% |
16,872
| – | – |
|
3338
Immunic
IMUX
$191M
| $30.5K | ﹤0.01% |
2,752
-135
| -5% | -$1.68K |
|
3339
CPS Technologies
CPSH
$77.3M
| $28.8K | ﹤0.01% |
16,936
-567
| -3% | -$997 |
|
3340
Rallybio
RLYB
$85.3M
| $28.4K | ﹤0.01% |
2,650
| – | – |
|
|
MRSN
3341
DELISTED
Mersana Therapeutics
MRSN
| $27.5K | ﹤0.01% |
548
-702
| -56% | -$50.8K |
|
|
VTYX
3342
DELISTED
Ventyx Biosciences
VTYX
| $27K | ﹤0.01% |
11,658
-352
| -3% | -$1.46K |
|
3343
Alpha Teknova
TKNO
$271M
| $26.2K | ﹤0.01% |
19,126
-8,225
| -30% | -$15.7K |
|
3344
Vor Biopharma
VOR
$1.18B
| $24.2K | ﹤0.01% |
1,211
-35
| -3% | -$1.13K |
|
|
DNMR
3345
DELISTED
Danimer Scientific, Inc.
DNMR
| $22.6K | ﹤0.01% |
937
| – | – |
|
3346
BlackSky Technology
BKSY
$919M
| $22.2K | ﹤0.01% |
2,592
| – | – |
|
3347
Corvus Pharmaceuticals
CRVS
$1.11B
| $21.7K | ﹤0.01% |
11,924
| – | – |
|
3348
AquaBounty Technologies
AQB
$4.68M
| $21.2K | ﹤0.01% |
12,770
| – | – |
|
3349
Bionano Genomics
BNGO
$12.2M
| $21K | ﹤0.01% |
517
-305
| -37% | -$16.8K |
|
3350
Great Elm Group
GEG
$68.4M
| $20.6K | ﹤0.01% |
11,419
-31,536
| -73% | -$57.9K |
|
Similar funds
Dimensional Fund Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Dimensional Fund Advisors held 3,454 positions worth $383B, up 3.7% from $369B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Dimensional Fund Advisors deployed $16B of net new capital in Q2 2024, opening 67 new positions and adding to 1,988 existing holdings. Its largest new stake was GE Vernova: 1,030,545 shares worth $177M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Broadcom, an estimated $957M trimmed.
- Dimensional Fund Advisors's largest Q2 2024 buy was GE Vernova: 1,030,545 shares worth $177M.
- Dimensional Fund Advisors added most to NVIDIA in Q2 2024, an estimated $1.7B increase.
- Dimensional Fund Advisors's biggest Q2 2024 reduction was Broadcom, cutting an estimated $957M.
- Dimensional Fund Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $477M.
- Dimensional Fund Advisors's ten largest holdings make up 16% of its $383B portfolio in Q2 2024.
- Dimensional Fund Advisors opened 67 new positions and closed 81 in Q2 2024.
- Dimensional Fund Advisors's portfolio value rose 3.7% quarter-over-quarter to $383B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.